{"id":"https://openalex.org/W2395038895","doi":"https://doi.org/10.1097/cad.0000000000000271","title":"RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models","display_name":"RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models","alternate_titles":[],"publication_year":2015,"publication_date":"2015-07-11","ids":{"openalex":"https://openalex.org/W2395038895","doi":"https://doi.org/10.1097/cad.0000000000000271","mag":"2395038895","pmid":"https://pubmed.ncbi.nlm.nih.gov/26164151","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4560273"},"language":"en","primary_location":{"id":"doi:10.1097/cad.0000000000000271","doi":"https://doi.org/10.1097/cad.0000000000000271","is_oa":true,"landing_page_url":"https://doi.org/10.1097/cad.0000000000000271","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2395038895"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1097/cad.0000000000000271","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Fiona Garner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093176","display_name":"Radius Health (United States)","ror":"https://ror.org/00m2x3q29","country_code":"US","type":"company","lineage":["https://openalex.org/I4210093176"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Fiona Garner","raw_affiliation_strings":["aRadius Health Inc., Waltham bPfizer, Andover, Massachusetts, USA","Radius Health Inc., Waltham","e-mail: [email\u00a0protected]","fax: +1 617 551 4701","to Fiona Garner, Radius Health Inc., 950 Winter Street, Waltham, MA 02451, USA Tel: +1 617 551 4700"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aRadius Health Inc., Waltham bPfizer, Andover, Massachusetts, USA","institution_ids":["https://openalex.org/I4210093176"]},{"raw_affiliation_string":"Radius Health Inc., Waltham","institution_ids":["https://openalex.org/I4210093176"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 617 551 4701","institution_ids":[]},{"raw_affiliation_string":"to Fiona Garner, Radius Health Inc., 950 Winter Street, Waltham, MA 02451, USA Tel: +1 617 551 4700","institution_ids":["https://openalex.org/I4210093176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028072650","display_name":"Maysoun Shomali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093176","display_name":"Radius Health (United States)","ror":"https://ror.org/00m2x3q29","country_code":"US","type":"company","lineage":["https://openalex.org/I4210093176"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maysoun Shomali","raw_affiliation_strings":["Radius Health Inc., Waltham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radius Health Inc., Waltham","institution_ids":["https://openalex.org/I4210093176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066267576","display_name":"Dotty Paquin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dotty Paquin","raw_affiliation_strings":["Pfizer, Andover, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Andover, Massachusetts, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111676212","display_name":"C. Richard Lyttle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093176","display_name":"Radius Health (United States)","ror":"https://ror.org/00m2x3q29","country_code":"US","type":"company","lineage":["https://openalex.org/I4210093176"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Richard Lyttle","raw_affiliation_strings":["Radius Health Inc., Waltham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radius Health Inc., Waltham","institution_ids":["https://openalex.org/I4210093176"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042999308","display_name":"Gary Hattersley","orcid":"https://orcid.org/0000-0001-5487-7703","observed_orcids":["https://orcid.org/0000-0001-5487-7703"]},"institutions":[{"id":"https://openalex.org/I4210093176","display_name":"Radius Health (United States)","ror":"https://ror.org/00m2x3q29","country_code":"US","type":"company","lineage":["https://openalex.org/I4210093176"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Hattersley","raw_affiliation_strings":["Radius Health Inc., Waltham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radius Health Inc., Waltham","institution_ids":["https://openalex.org/I4210093176"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210093176"],"apc_list":null,"apc_paid":null,"fwci":7.3071,"has_fulltext":true,"cited_by_count":169,"citation_normalized_percentile":{"value":0.98811646,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"26","issue":"9","first_page":"948","last_page":"956"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.9169999957084656,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.9169999957084656,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.06620000302791595,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selective-estrogen-receptor-degrader","display_name":"selective estrogen receptor degrader","score":0.9110000133514404},{"id":"https://openalex.org/keywords/estrogen-receptor","display_name":"estrogen receptor","score":0.6970000267028809},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.953000009059906},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.7210000157356262},{"id":"https://openalex.org/keywords/oral-small-molecule-drug","display_name":"oral small-molecule drug","score":0.671999990940094},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.7820000052452087},{"id":"https://openalex.org/keywords/mcf-7-xenografts","display_name":"MCF-7 xenografts","score":0.8889999985694885},{"id":"https://openalex.org/keywords/ovariectomy-induced-bone-loss","display_name":"ovariectomy-induced bone loss","score":0.8450000286102295},{"id":"https://openalex.org/keywords/estrogen-agonist-activity","display_name":"estrogen agonist activity","score":0.4909999966621399},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.8109999895095825}],"concepts":[{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.8948046565055847},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7700997591018677},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.7152721285820007},{"id":"https://openalex.org/C2776166826","wikidata":"https://www.wikidata.org/wiki/Q415287","display_name":"Aromatase","level":4,"score":0.685645341873169},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.6082468628883362},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5884381532669067},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5087376236915588},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5026018619537354},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.49483388662338257},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.463497132062912},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.44197404384613037},{"id":"https://openalex.org/C172313692","wikidata":"https://www.wikidata.org/wiki/Q14902310","display_name":"Estrogen receptor alpha","level":5,"score":0.439573734998703},{"id":"https://openalex.org/C46699223","wikidata":"https://www.wikidata.org/wiki/Q11078","display_name":"Endocrine system","level":3,"score":0.42746931314468384},{"id":"https://openalex.org/C2777944059","wikidata":"https://www.wikidata.org/wiki/Q903917","display_name":"Selective estrogen receptor modulator","level":5,"score":0.4267841875553131},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4036462903022766},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3861854672431946},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.34387046098709106},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3400824964046478},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.2052098512649536}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010024","descriptor_name":"Osteoporosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010024","descriptor_name":"Osteoporosis","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D010024","descriptor_name":"Osteoporosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D010052","descriptor_name":"Ovariectomy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014599","descriptor_name":"Uterus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014599","descriptor_name":"Uterus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015519","descriptor_name":"Bone Density","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047628","descriptor_name":"Estrogen Receptor alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D061986","descriptor_name":"MCF-7 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062367","descriptor_name":"ortho-Aminobenzoates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D064593","descriptor_name":"Heterografts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/cad.0000000000000271","doi":"https://doi.org/10.1097/cad.0000000000000271","is_oa":true,"landing_page_url":"https://doi.org/10.1097/cad.0000000000000271","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4560273","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4560273/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4560273/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer Drugs","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:3553889","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4560273","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:26164151","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26164151","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1097/cad.0000000000000271","doi":"https://doi.org/10.1097/cad.0000000000000271","is_oa":true,"landing_page_url":"https://doi.org/10.1097/cad.0000000000000271","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320316098","display_name":"Radius Health","ror":"https://ror.org/00m2x3q29"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2395038895.pdf","grobid_xml":"https://content.openalex.org/works/W2395038895.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W77347164","https://openalex.org/W1987398734","https://openalex.org/W1988411979","https://openalex.org/W2002842589","https://openalex.org/W2016203922","https://openalex.org/W2016908879","https://openalex.org/W2019311111","https://openalex.org/W2027093084","https://openalex.org/W2028691872","https://openalex.org/W2038933398","https://openalex.org/W2070894000","https://openalex.org/W2085124463","https://openalex.org/W2098505104","https://openalex.org/W2115103771","https://openalex.org/W2117634794","https://openalex.org/W2142334766","https://openalex.org/W2167210028","https://openalex.org/W2302169224","https://openalex.org/W2323968754","https://openalex.org/W2401529260","https://openalex.org/W4254152438"],"related_works":["https://openalex.org/W1522885684","https://openalex.org/W2243467818","https://openalex.org/W2407256050","https://openalex.org/W2405772768","https://openalex.org/W2593215104","https://openalex.org/W2624358087","https://openalex.org/W2486013003","https://openalex.org/W2593965059","https://openalex.org/W2399700463","https://openalex.org/W2412459870"],"abstract_inverted_index":{"Agents":[0],"that":[1,11,177,197],"inhibit":[2],"estrogen":[3,14,21,26,98],"production,":[4],"such":[5,18],"as":[6,19,202,208],"aromatase":[7],"inhibitors":[8],"or":[9,162],"those":[10,157],"directly":[12],"block":[13],"receptor":[15,22,27,99],"(ER)":[16],"activity,":[17],"selective":[20,25,97],"modulators":[23],"and":[24,68,82,90,102,117,121,137,189,213],"degraders,":[28],"are":[29],"routinely":[30],"used":[31],"in":[32,143,170,205,211,222],"the":[33,61,71,108,119,165,171,181,191],"treatment":[34,42,109,172],"of":[35,60,73,110,126,140,168,173,194],"ER-positive":[36,127,174,226],"breast":[37,55,111,128,175,212,228],"cancers.":[38,56],"However,":[39],"although":[40],"initial":[41],"with":[43,53,64,159,225],"these":[44],"agents":[45],"is":[46,76,122,217],"often":[47],"successful,":[48],"many":[49],"women":[50,224],"eventually":[51],"relapse":[52],"drug-resistant":[54],"To":[57],"overcome":[58],"some":[59],"challenges":[62],"associated":[63],"current":[65],"endocrine":[66],"therapies":[67],"to":[69,116,180],"combat":[70],"development":[72],"resistance,":[74],"there":[75],"a":[77,92,123,135],"need":[78],"for":[79,107],"more":[80,83],"durable":[81],"effective":[84],"ER-targeted":[85],"therapies.":[86],"Here":[87],"we":[88],"describe":[89],"characterize":[91],"novel,":[93],"orally":[94],"bioavailable":[95],"small-molecule":[96],"degrader,":[100],"RAD1901,":[101],"evaluate":[103],"its":[104],"therapeutic":[105],"potential":[106,166],"cancer.":[112,229],"RAD1901":[113,133,169,184,216],"selectively":[114,201],"binds":[115],"degrades":[118],"ER":[120],"potent":[124],"antagonist":[125,210],"cancer":[129,176],"cell":[130],"proliferation.":[131],"Importantly,":[132],"produced":[134],"robust":[136],"profound":[138],"inhibition":[139],"tumor":[141],"growth":[142],"MCF-7":[144,150],"xenograft":[145],"models.":[146],"In":[147],"an":[148,203,209],"intracranial":[149],"model,":[151],"RAD1901-treated":[152],"animals":[153],"survived":[154],"longer":[155],"than":[156],"treated":[158],"either":[160],"control":[161],"fulvestrant,":[163],"suggesting":[164,196],"benefit":[167],"has":[178],"metastasized":[179],"brain.":[182],"Finally,":[183],"preserved":[185],"ovariectomy-induced":[186],"bone":[187,206],"loss":[188],"prevented":[190],"uterotropic":[192],"effects":[193],"E2,":[195],"it":[198],"may":[199],"act":[200],"agonist":[204],"but":[207],"uterine":[214],"tissues.":[215],"currently":[218],"under":[219],"clinical":[220],"study":[221],"postmenopausal":[223],"advanced":[227]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2395038895","counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":20},{"year":2024,"cited_by_count":19},{"year":2023,"cited_by_count":24},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":17},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":16},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":11}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
